Literature DB >> 12916029

Chemistry and biology of roseophilin and the prodigiosin alkaloids: a survey of the last 2500 years.

Alois Fürstner1.   

Abstract

The pyrrole alkaloids of the prodigiosin family make up an unusual chapter in the chemistry of natural products. Owing to the characteristic red color of these secondary metabolites, colonies of the Gram-negative-producing bacteria may strikingly resemble droplets of blood. This phenomenon caused considerable confusion in the past and was likely responsible for many seemingly miraculous (prodigious) events. After the eventual transition from superstition to science, the prodigiosins started to attract considerable attention because of their promising physiological properties. Most interesting are the immunosuppressive activities at doses that are not cytotoxic, in particular since in vivo studies suggest that the prodigiosins act synergistically with cyclosporine A or FK 506, which are presently the dominant drugs in clinical immunosuppressive regimens. Furthermore, the chemistry of the closely related and structurally rather unique alkaloid roseophilin is summarized, a cytotoxic agent that recently became the focal point of many innovative total syntheses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12916029     DOI: 10.1002/anie.200300582

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  70 in total

Review 1.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

2.  Synthesis of 1-(4-trifluoromethoxyphenyl)-2,5-dimethyl-3-(2-R-thiazol-4-yl)-1H-pyrroles via chain heterocyclization.

Authors:  Mykhaylo V Vovk; Oleksandr M Pinchuk; Andrij O Tolmachov; Andrei A Gakh
Journal:  Molecules       Date:  2010-02-23       Impact factor: 4.411

3.  Chiral Brønsted base-promoted nitroalkane alkylation: enantioselective synthesis of sec-alkyl-3-substituted indoles.

Authors:  Mark C Dobish; Jeffrey N Johnston
Journal:  Org Lett       Date:  2010-11-19       Impact factor: 6.005

4.  Formal synthesis of (+/-)-roseophilin.

Authors:  Abdallah Y Bitar; Alison J Frontier
Journal:  Org Lett       Date:  2009-01-01       Impact factor: 6.005

5.  Optimization of physicochemical parameters influencing the production of prodigiosin from Serratia nematodiphila RL2 and exploring its antibacterial activity.

Authors:  Vijay Singh Gondil; Mohammad Asif; Tek Chand Bhalla
Journal:  3 Biotech       Date:  2017-09-20       Impact factor: 2.406

6.  Optimization of the culture condition for an antitumor bacterium Serratia proteamacula 657 and identification of the active compounds.

Authors:  Li Miao; Xueling Wang; Wei Jiang; Shengping Yang; Huiru Zhou; Youpeng Zhai; Xiaojian Zhou; Kunming Dong
Journal:  World J Microbiol Biotechnol       Date:  2012-12-28       Impact factor: 3.312

7.  Efficient domino approaches to multifunctionalized fused pyrroles and dibenzo[b,e][1,4]diazepin-1-ones.

Authors:  Bo Jiang; Qiu-Yun Li; Hao Zhang; Shu-Jiang Tu; Suresh Pindi; Guigen Li
Journal:  Org Lett       Date:  2012-01-19       Impact factor: 6.005

8.  Modular access to complex prodiginines: total synthesis of (+)-roseophilin via its 2-azafulvene prototropisomer.

Authors:  James H Frederich; Patrick G Harran
Journal:  J Am Chem Soc       Date:  2013-03-01       Impact factor: 15.419

Review 9.  Scrutinizing the scaffolds of marine biosynthetics from different source organisms: Gram-negative cultured bacterial products enter center stage.

Authors:  Patrick C Still; Tyler A Johnson; Christine M Theodore; Steven T Loveridge; Phillip Crews
Journal:  J Nat Prod       Date:  2014-02-26       Impact factor: 4.050

10.  meso-octamethylcalix[4]pyrrole: an old yet new transmembrane ion-pair transporter.

Authors:  Christine C Tong; Roberto Quesada; Jonathan L Sessler; Philip A Gale
Journal:  Chem Commun (Camb)       Date:  2008-10-21       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.